1970
DOI: 10.1016/s0140-6736(70)92358-5
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Combined Œstrogen-Progestogen Oral Contraceptives, Œstrogen, and Progestogen on Antiplasmin and Antithrombin Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
37
1
2

Year Published

1975
1975
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(41 citation statements)
references
References 32 publications
1
37
1
2
Order By: Relevance
“…The influence of oral contracep tives on the plasma plasminogen level is less well established. Whereas P hillips et al [26], H ow ie et al [14] and A mris and Starup [3] ob served an increase in the plasminogen level, Brakman and A strup [4] found no difference in the mean plasminogen level between hormonetreated and control women. Our results support the former conclusion.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…The influence of oral contracep tives on the plasma plasminogen level is less well established. Whereas P hillips et al [26], H ow ie et al [14] and A mris and Starup [3] ob served an increase in the plasminogen level, Brakman and A strup [4] found no difference in the mean plasminogen level between hormonetreated and control women. Our results support the former conclusion.…”
Section: Discussionmentioning
confidence: 93%
“…A rise in «2-macroglobulin and «,-antitrypsin during oestrogen-progestogen therapy has been well documented [13,14,18]. The influence of oral contracep tives on the plasma plasminogen level is less well established.…”
Section: Discussionmentioning
confidence: 99%
“…This syndrome has been associated with many disparate conditions, such as pregnancy toxaemia, septicaemia, amniotic fluid embolism, hypertension, snake bite and shock (e.g., the reviews by Pitney, 1971 and Simpson and Stalker, 1973 Pregnancy is associated with changes in the fibrinogen/plasminogen system, although the details are still subject to dispute probably related to technical differences (Woodfield et al, 1968;Bonnar et al, 1969). A variety of changes in coagulation factors and their inhibitors have been observed in patients receiving oestrogen-progestogen preparations (e.g., Brackman and Astrup, 1964;Ygge et al, 1969;Howie et al, 1970). Whereas the precise mechanism of an enhanced thrombotic tendency is still disputed, its existence is sufficiently well established to provide a good theoretical basis for the observed clinical association, particularly related to the oestrogen content of the pill (British Medical Journal, 1974).…”
Section: Discussionmentioning
confidence: 99%
“…Antithrombin III (AT III) activity fell significantly during OCP useand the estrogen component was blamed for the fall 13,14 . Low serum ATIII activity was observed in patients with pulmonary embolism,MI and venous thrombosis.…”
Section: Original Articlesmentioning
confidence: 99%